Chinese asset manager Harvest Global Investments has led a US$50 million series C round of financing in Shanghai-based drug developer Hua Medicine, the company said in an announcement (in Chinese). Existing investor Frontline BioVentures also participated in the round, which is a dual-currency deal including both U.S. dollar and RMB investments. In January 2015, Hua […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.